Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[We conclude, that patients with type 2 diabetes and the 63bp deletion in the promoter of RAGE seem to be protected from diabetic nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[We conclude, that patients with type 2 diabetes and the 63bp deletion in the promoter of RAGE seem to be protected from diabetic nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We conclude, that patients with type 2 diabetes and the 63bp deletion in the promoter of RAGE seem to be protected from diabetic nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP156286.RAd8lyJu9WcpzOGsHR14jFDYhuhW6Y_KtWVCzKfe2jxLU130_assertion description "[We conclude, that patients with type 2 diabetes and the 63bp deletion in the promoter of RAGE seem to be protected from diabetic nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP156286.RAd8lyJu9WcpzOGsHR14jFDYhuhW6Y_KtWVCzKfe2jxLU130_provenance.
• NP272764.RA2ONfvFoweElbLlx3J7VtM1j2aTlfiRFBeHhEZlbzZ-4130_assertion description "[We conclude, that patients with type 2 diabetes and the 63bp deletion in the promoter of RAGE seem to be protected from diabetic nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP272764.RA2ONfvFoweElbLlx3J7VtM1j2aTlfiRFBeHhEZlbzZ-4130_provenance.
• NP498806.RANk5szTNefeTheX8p-4BNju_l9ungFs_gUeB_xPwP1GQ130_assertion description "[We conclude, that patients with type 2 diabetes and the 63bp deletion in the promoter of RAGE seem to be protected from diabetic nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP498806.RANk5szTNefeTheX8p-4BNju_l9ungFs_gUeB_xPwP1GQ130_provenance.
• assertion description "[We conclude, that patients with type 2 diabetes and the 63bp deletion in the promoter of RAGE seem to be protected from diabetic nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP437668.RAW9iyZf2bnUVs2KNZL52PQnbUPzheKu106RIadUk2kuo130_assertion description "[We conclude, that patients with type 2 diabetes and the 63bp deletion in the promoter of RAGE seem to be protected from diabetic nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP437668.RAW9iyZf2bnUVs2KNZL52PQnbUPzheKu106RIadUk2kuo130_provenance.
• NP228307.RAsnEgG3YC0HQ97tmTCD209BPPQQ4Lh4Jaay7rBtTPNTo130_assertion description "[We conclude, that patients with type 2 diabetes and the 63bp deletion in the promoter of RAGE seem to be protected from diabetic nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP228307.RAsnEgG3YC0HQ97tmTCD209BPPQQ4Lh4Jaay7rBtTPNTo130_provenance.
• NP664035.RAqQzvXhTKqLy0DxnIp5w8vliGyQwwH-W04wi_M5MvXSo130_assertion description "[We conclude, that patients with type 2 diabetes and the 63bp deletion in the promoter of RAGE seem to be protected from diabetic nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP664035.RAqQzvXhTKqLy0DxnIp5w8vliGyQwwH-W04wi_M5MvXSo130_provenance.
• NP437665.RAgoDpY5FJXo8xbJif9ZAUWMj-ro4rSGPD-mdAx508usg130_assertion description "[We conclude, that patients with type 2 diabetes and the 63bp deletion in the promoter of RAGE seem to be protected from diabetic nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP437665.RAgoDpY5FJXo8xbJif9ZAUWMj-ro4rSGPD-mdAx508usg130_provenance.
• NP437666.RAk2L5z8wA-teBcSEykBiFhF_h5dPncW4ZSHa4QwzdUD4130_assertion description "[We conclude, that patients with type 2 diabetes and the 63bp deletion in the promoter of RAGE seem to be protected from diabetic nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP437666.RAk2L5z8wA-teBcSEykBiFhF_h5dPncW4ZSHa4QwzdUD4130_provenance.
• NP437667.RAjTqyS9w18VarO_QOwmb9oBeLsbPrKOLyii0hkOB8hDw130_assertion description "[We conclude, that patients with type 2 diabetes and the 63bp deletion in the promoter of RAGE seem to be protected from diabetic nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP437667.RAjTqyS9w18VarO_QOwmb9oBeLsbPrKOLyii0hkOB8hDw130_provenance.
• NP437669.RApXTmPEN1WsSfrmvdACyt5YS7VC3-0GCLfTwyFaZnKes130_assertion description "[We conclude, that patients with type 2 diabetes and the 63bp deletion in the promoter of RAGE seem to be protected from diabetic nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP437669.RApXTmPEN1WsSfrmvdACyt5YS7VC3-0GCLfTwyFaZnKes130_provenance.
• NP1017670.RAl0SUZreOYqMZApQ8TU_ioMH1X_U9JnFqU7lTsTueXvg130_assertion description "[We conclude, that patients with type 2 diabetes and the 63bp deletion in the promoter of RAGE seem to be protected from diabetic nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1017670.RAl0SUZreOYqMZApQ8TU_ioMH1X_U9JnFqU7lTsTueXvg130_provenance.
• NP664023.RAMZ5c20Vv0iyXUKqQRSx5TkJGE4okPu3pEk89PeK6L5o130_assertion description "[We conclude, that patients with type 2 diabetes and the 63bp deletion in the promoter of RAGE seem to be protected from diabetic nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP664023.RAMZ5c20Vv0iyXUKqQRSx5TkJGE4okPu3pEk89PeK6L5o130_provenance.
• NP437664.RAJegg1QwKrNfyUHvFMXOTLAvyndz8OywVUa-tKfFusoQ130_assertion description "[We conclude, that patients with type 2 diabetes and the 63bp deletion in the promoter of RAGE seem to be protected from diabetic nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP437664.RAJegg1QwKrNfyUHvFMXOTLAvyndz8OywVUa-tKfFusoQ130_provenance.